[{"address1": "655 Elizabeth Street", "city": "Melbourne", "state": "VIC", "zip": "3000", "country": "Australia", "phone": "61 3 9389 1911", "fax": "61 3 9389 1434", "website": "https://www.csl.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.", "fullTimeEmployees": 29904, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul F. McKenzie Ph.D.", "age": 59, "title": "MD, CEO & Executive Director", "yearBorn": 1966, "fiscalYear": 2025, "totalPay": 4745548, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andy  Schmeltz", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2025, "totalPay": 1588530, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ken  Lim", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mary  Oates Ph.D.", "age": 62, "title": "Executive VP & COO", "yearBorn": 1963, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Chris  Cooper", "title": "Head of Investor Relations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory  Boss B.S., BS(Hons), J.D.", "age": 64, "title": "Executive VP of Legal & Group General Counsel", "yearBorn": 1961, "fiscalYear": 2025, "totalPay": 1095171, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Roanne  Parry", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1973, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Mezzanotte M.D., M.P.H.", "age": 66, "title": "Chief Medical Officer, Executive VP and Head of Research & Development", "yearBorn": 1959, "fiscalYear": 2025, "totalPay": 1455733, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Hill B.A., M.B.A.", "age": 64, "title": "Chief Digital Information Officer & Executive VP", "yearBorn": 1961, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Deirdre  BeVard", "title": "Senior Vice President of Research & Development Strategic Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 63.01, "open": 65.375, "dayLow": 63.83, "dayHigh": 65.655, "regularMarketPreviousClose": 63.01, "regularMarketOpen": 65.375, "regularMarketDayLow": 63.83, "regularMarketDayHigh": 65.655, "dividendRate": 1.46, "dividendYield": 2.27, "exDividendDate": 1757462400, "payoutRatio": 0.4457, "fiveYearAvgDividendYield": 1.35, "beta": 0.281, "trailingPE": 20.85065, "forwardPE": 16.40806, "volume": 6038, "regularMarketVolume": 6038, "averageVolume": 153985, "averageVolume10days": 176590, "averageDailyVolume10Day": 176590, "bid": 64.07, "ask": 64.23, "bidSize": 800, "askSize": 153, "marketCap": 62312845312, "fiftyTwoWeekLow": 54.1, "fiftyTwoWeekHigh": 89.71, "allTimeHigh": 117.98, "allTimeLow": 12.42, "priceToSalesTrailing12Months": 4.0051966, "fiftyDayAverage": 59.987, "twoHundredDayAverage": 70.5636, "trailingAnnualDividendRate": 2.92, "trailingAnnualDividendYield": 0.04634185, "currency": "USD", "tradeable": false, "enterpriseValue": 42509103104, "profitMargins": 0.19296, "floatShares": 483902227, "sharesOutstanding": 970302788, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00011, "impliedSharesOutstanding": 970302788, "bookValue": 39.931, "priceToBook": 1.6082743, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": 0.343, "netIncomeToCommon": 3001999872, "trailingEps": 3.08, "forwardEps": 3.91393, "enterpriseToRevenue": 2.732, "enterpriseToEbitda": 8.659, "52WeekChange": -0.2551129, "SandP52WeekChange": 0.120657206, "lastDividendValue": 0.65, "lastDividendDate": 1741651200, "quoteType": "EQUITY", "currentPrice": 64.22, "targetHighPrice": 92.0, "targetLowPrice": 92.0, "targetMeanPrice": 92.0, "targetMedianPrice": 92.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 2156999936, "totalCashPerShare": 4.455, "ebitda": 4909000192, "totalDebt": 11498000384, "quickRatio": 1.064, "currentRatio": 2.461, "totalRevenue": 15557999616, "debtToEquity": 53.711, "revenuePerShare": 16.071, "returnOnAssets": 0.06626, "returnOnEquity": 0.1537, "grossProfits": 8079000064, "freeCashflow": 1878499968, "operatingCashflow": 3560999936, "earningsGrowth": 0.333, "revenueGrowth": 0.049, "grossMargins": 0.51928, "ebitdaMargins": 0.31553, "operatingMargins": 0.18827, "financialCurrency": "USD", "symbol": "CSLLY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": 1.9203348, "regularMarketPrice": 64.22, "marketState": "CLOSED", "shortName": "CSL Ltd.", "longName": "CSL Limited", "exchange": "OQX", "messageBoardId": "finmb_881503", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [{"header": "Stock Dividend", "message": "CSLLY announced a 100% stock dividend with an ex-date of Mar. 2, 2026", "meta": {"eventType": "STOCK_DIVIDEND", "dateEpochMs": 1772427600000, "percent": "100%"}}], "regularMarketTime": 1770411518, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1262097000000, "regularMarketChange": 1.2100029, "regularMarketDayRange": "63.83 - 65.655", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 153985, "fiftyTwoWeekLowChange": 10.120003, "fiftyTwoWeekLowChangePercent": 0.18706106, "fiftyTwoWeekRange": "54.1 - 89.71", "fiftyTwoWeekHighChange": -25.489998, "fiftyTwoWeekHighChangePercent": -0.28413776, "fiftyTwoWeekChangePercent": -25.511288, "dividendDate": 1760054400, "earningsTimestamp": 1770757200, "earningsTimestampStart": 1770757200, "earningsTimestampEnd": 1770757200, "earningsCallTimestampStart": 1770764400, "earningsCallTimestampEnd": 1770764400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 3.08, "epsForward": 3.91393, "epsCurrentYear": 3.52423, "priceEpsCurrentYear": 18.22242, "fiftyDayAverageChange": 4.2330017, "fiftyDayAverageChangePercent": 0.07056532, "twoHundredDayAverageChange": -6.3435974, "twoHundredDayAverageChangePercent": -0.089899, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]